News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Benz Edward J. JR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 12/05/2022 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Renovacor, Inc.|
Txns:
| Granted 3,586 shares
@ $0
Disposed/sold 3,586 shares
@ $0
Disposed/sold 9,060 options
@ $0
Disposed/sold 24,000 options
@ $0
Disposed/sold 12,000 options
@ $0 |
|
| 10/17/2022 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $56.46, valued at
$677.5k
|
|
| 06/13/2019 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $21.05, valued at
$252.6k
|
|
| 05/21/2018 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $25.73, valued at
$308.8k
|
|
| 10/02/2017 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 6,236 options to buy
@ $3.95, valued at
$24.6k
Exercised 35,233 options to buy
@ $3.95, valued at
$139.2k
Exercised 1,271 options to buy
@ $6.13, valued at
$7.8k
Exercised 7,181 options to buy
@ $6.13, valued at
$44k
|
|
| 08/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|